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Hypertension (HTN) is found in about 3-4% of the pediatric population with long-term risks of end organ damage if untreated or
poorlycontrolled.AlthoughchildrenwithHTNarebeingmorefrequentlyscreenedforendorgandamage(i.e.,LVH),thecognitive
eﬀectsofHTNandmethodstoscreenforcognitivedysfunctionhave notbeenextensivelyexplored.Inrecentyears,therehavebeen
a small number of studies that have provided important insights that can guide future research in this area. These studies show
that HTN can be associated with headaches, restlessness, sleep disturbance, anxiety, depression, decreased attention, and also poor
executive functioning. By increasing the utilization of cognitive tests in hypertensive children and adolescents, important cognitive
defects secondary to HTN may be detected. More research is needed in the area, and the results of future studies could have far
reaching implications for long-term outcomes in hypertensive children and adolescents.
1.Introduction
The prevalence of hypertension (HTN) is increasing in
the pediatric population and is now up to 3-4% [1]. In
adults, HTN is recognized to have multiple acute and
chroniccomplicationsincludingnegativeeﬀectsoncognitive
function. The long-term health risk for pediatric patients
withHTNcanhavefarreachingeﬀects.Therefore,guidelines
have been developed to assist in early and accurate diagnosis
of HTN in order to minimize risk of end organ damage
[2]. In pediatrics, hypertension is deﬁned as a systolic
and/or diastolic blood pressure (BP) ≥ 95th percentile for
age, gender, and height on three or more readings [2].
It is becoming more common for practitioners to screen
children with HTN for end organ damage, primarily left
ventricular hypertrophy [3]. While there has been some
focus on cognition in adult hypertensive patients, the eﬀects
of HTN on cognition in pediatric patients remain largely
unexplored. More recently, a small number of studies on the
cognitive eﬀects of HTN in children have been published
that provide important insights [3–5]. This paper highlights
recently reported cognitive eﬀects of pediatric HTN along
with potential cognitive eﬀects of long-term HTN.
2. CognitiveDevelopment
Cognitive development is an active and ongoing process that
is inﬂuenced by both internal and external stimuli from
infancy to adolescence [6]. Developmental rates vary and are
inﬂuencedbybothinnatecapacityandexternalstimuli.With
time and experience, the number and complexity of synaptic
connectionsandneuralplasticitypromotesincreasingcogni-
tive sophistication. In infancy, the increase in neural connec-
tions results in rapid neurological growth and development.
This is reﬂected in the achievement of developmental mile-
stones in gross motor, ﬁne motor, language, and social skills.
Developmental sequences are important in achieving
full potential. Looking at one speciﬁc aspect of cognition,
language, studies have shown that children with continued
language disorders have more diﬃculties in adulthood
compared to normal controls [7]. Children with language
disorders often do not outgrow their impairments and if the
languagedisorderisnotcorrectedbyschoolage,itcanpersist
into early adulthood [7]. Language impaired adults have a
higher rate of unemployment, lower socioeconomic status,
and lower levels of education when compared to normal
controls [7–9].2 International Journal of Pediatrics












































Figure 1: Connecting line graph of cerebral autoregulation in adult
normotensive patients versus adult hypertensive patients.
3. Pathophysiology of HTN on the Central
Nervous System
3.1. Adults. In adults, the hypertensive eﬀects on the brain
are thought to be due to systolic blood pressure exceeding
the autoregulatory mechanisms of the brain (Figure 1).
This results in damage to small cerebral vessels that can
lead to impaired autoregulation, lacunar infarcts, amyloid
angiopathy, and even cerebral atrophy [10]. In adults, the
amyloid angiopathy and cerebral atrophy can look similar to
Alzheimer’s disease [10]. These changes make it diﬃcult to
diﬀerentiate HTN that is associated with Alzheimer’s disease
from vascular dementia secondary to HTN.
Cognitive deﬁcits in adults from HTN can be diﬃcult to
detect but may be divided into several domains including
learning, memory, and attention [11]. The blood vessels in
the prefrontal subcortical areas are often aﬀected by severe
HTN,whichcanaﬀecttheabilitytomakeexecutivedecisions
(e.g., planning, attention, problem solving, verbal reasoning,
etc.). Interestingly, Jennings et al. showed that adults with
HTN had reduced cerebral blood ﬂow to areas of the brain
that are normally active during performance of cognitive
taskspertainingtomemory[12,13].Theyalsodemonstrated
that hypertensive individuals compensate for decreased cere-
bral blood ﬂow by increasing blood ﬂow to other areas of the
brain. Overtime, these cerebralchanges canbe manifested in
cognitiveorbehavioralchangesincludingsleepdisturbances,
concentration diﬃculties, and fatigue.
3.2. Pediatrics. Currently, most of the information on the
pathophysiological eﬀects of HTN on the pediatric central
nervous system (CNS) relates to hypertensive encephalopa-
thy [10]. When there is an acute severe elevation in blood
pressure, children can present with seizures, ischemic, or
hemorrhagic strokes, or even hypertensive encephalopathy
[10]. This hypertensive emergency can be manifested as pos-
terior reversible encephalopathy syndrome (PRES). Patients
who develop PRES will commonly present with complaints
Figure 2: MRI T2 ﬂair image demonstrating ﬁndings of posterior
reversible encephalopathy syndrome involving bilateral parietal-
occipital lobes, left greater than right (arrows).
of headache, visual changes, mental status changes, and
can develop seizures. The diagnosis can be conﬁrmed with
the characteristic white matter changes seen on brain MRI
in the posterior parietal and occipital regions (Figure 2).
These changes can also be seen in the frontal lobes, basal
ganglia, cerebellum, and brainstem. They are often seen
symmetrically on imaging but asymmetrical lesions can
be seen [14]. PRES is thought to result from a failure of
the normal cerebral autoregulation in the vertebrobasilar
vascular system leading to endothelial dysfunction, which
ultimately results in localized areas of cerebral edema [14].
Once BP exceeds the upper limit of the autoregulatory
system, the increased pressure is transmitted to the cerebral
vasculature, especially the small vessels, leading to endothe-
lial damage [10]. The disruption of the endothelium leads to
increased vascular wall permeability, cell proliferation, and
activation of the coagulation cascade, which ultimately leads
to edema and tissue ischemia. It is possible that endothelial
damage on a lesser scale than that seen in hypertensive
encephalopathy aﬀects cognitive function but this needs to
be further examined. In addition, endothelial damage could
be a forerunner for atherosclerosis in the future. In adults,
carotid artery intima-media thickness (cIMT) is considered
a surrogate marker for atherosclerosis [15]. cIMT has been
shown to be increased in hypertensive pediatric patients
suggesting early subclinical vascular injury and possible
earlyatherosclerosis[16].Thus,pediatrichypertensioncould
be a risk factor for early atherosclerotic lesions. These
lesionscouldpotentiallydevelopthroughoutthevasculature,
but their eﬀects on cerebral vasculature and its cognitive
implications are unclear at this time.
The cognitive eﬀects of HTN may also be in part
related to inﬂammation. Lande et al. reported an association
between elevated C-reactive protein (CRP) and elevated
blood pressure in children and adolescents [17]. They
showed that children and adolescents aged 8–17 years old
participating in the Third National Health and Nutrition
Examination Survey (NHANES III) with an elevated CRP
level greater than 3mg/L had higher systolic blood pressures
when compared to those participants with a CRP less
than or equal to 3mg/L. In adults, an elevated CRP has
been associated with cognitive impairments including in
the area of visuospatial functioning [18]. Visuospatial skills
are important for analyzing and understanding space which
enablespeopletorecreatetheworldthroughmentalimagery.International Journal of Pediatrics 3
4. CognitiveImpairments from HTN
4.1.Adults. Severalbehavioralandcognitivestudiesinadults
have shown the negative eﬀects of high blood pressure in
the brain with resultant improvement after antihypertensive
treatment. Shapiro et al. administered four behavioral tasks
to 41 mildly hypertensive and 41 normotensive patients [19].
The hypertensive patients had signiﬁcant behavioral impair-
ment in three of the tasks: sensory-perceptual, cognitive,
and psychomotor. They also showed that HTN seemed to
preferentiallyaﬀectbehaviorsthatneededtobeself-initiated.
Miller et al. did a follow-up study where they tested the par-
ticipants in the above study after 15 months of observation
and treatment and compared them to normotensive indi-
viduals [20]. Those receiving antihypertensive therapy had
a signiﬁcant improvement of all behavioral-cognitive scores,
which approached those of the normotensive control group.
Adult studies have demonstrated a variety of cognitive
impairments associated with HTN. Essential hypertensive
patients scored lower compared to normotensive patients
on neuropsychological testing for speed, memory, spatial
localization, simple motor skills, and learning [21]. The dif-
ference, however, was not apparent in everyday functioning
capabilities.
Waldstein et al. showed that 20 untreated, mildly hyper-
tensive adult males did poorer on learning and memory
tests involving recall of visual stimuli compared to their nor-
motensivecontrols[22].Arelationshipbetweenpoorperfor-
mance on cognitive tests and increased systolic blood pres-
sure was found in 2727 men and women of ages 20 to 59 who
participated in NHANES III [23]. Speciﬁcally, they found
that patients with HTN did worse on the serial digit learning
test, which is a measure of attention and concentration.
Elevateddiastolicbloodpressureinadultsmaybepredic-
tive of future cognitive function impairment [24]. A total of
999 men from the age of 50 through 70 were followed for up
to 20 years. Cognitive function was assessed with the mini-
mental state examination and trail-making test. The trail-
making test is a neuropsychiatric test of visual attention and
alternation of tasks. They found that low cognitive function
was related to an elevated mean nocturnal diastolic blood
pressure and nondipping pattern obtained from 24-hour
ambulatory blood pressure monitoring. This relationship
was greatest in those men who were not on antihypertensive
treatment during the 20-year interim period.
It is known that adults with depression and anxiety
have a higher prevalence of HTN, which may indicate that
having HTN as a comorbidity may exacerbate psychiatric
disorders [25]. The mechanism behind this association is
still unclear. Of note, there was a study in adults with
HTNwhoexperiencedimprovementoftheirdepressionafter
administration of Captopril [26].
4.2. Pediatrics. In pediatrics, there have been several studies
that demonstrated lower cognitive function in children and
adolescents with hypertension. Lande et al. showed that
participants aged 6–16 years old in the NHANES III who
had a systolic blood pressure above the 90th percentile for
height, age, and gender scored lower in short-term memory,
attention, and concentration compared to their counterparts
who had systolic blood pressure below the 90th percentile
[3]. Those participants who were equal to or above the
95th percentile scored even lower when compared to the
normotensive participants. The participants were asked to
recite back random numbers in forward succession and
then backwards. This study showed that, like in adults,
psychological testing could be used to detect cognitive
abnormalities in pediatric patients with HTN [21].
Lande et al. later reported the use of parental assessments
to determine eﬀects of HTN on behavior and executive
functioning in children [27]. In this study, parents of
untreated and newly diagnosed hypertensive patients aged
10–18 yearsold weregivenchecklists to assesstheir children’s
behavior. Nonhypertensive children were used as a control
group. The authors found that hypertensive children had
more problems with behavior and mood disturbances such
as anxiety, depression, and problems with attention com-
pared to the control group. They also had poorer executive
functioning when compared to the normotensive children.
Executivefunctioningwasmeasuredbyabehaviorinventory,
which was also reported by the parents. In their follow-up
study, Lande et al. demonstrated improvement in executive
functioning after 12 months of antihypertensive treatment.
Executive functioning was deﬁned with the same parental
inventory method [28].
Adams et al. did a retrospective study of 201 patients
age 10–18 years old who were referred to their institution
for HTN evaluation [4]. One hundred patients had HTN
and 101 were normotensive. Learning disabilities were more
common in the patients who had a diagnosis of HTN. A
learning disability was deﬁned as having an individualized
learning plan or section 504 plan in school. Whether the
learning disabilities predated the diagnosis of HTN or were
exacerbated by HTN was not evaluated by the design of this
study.
An interesting study was reported by Krause et al. in
which they surveyed parents of children who had been
diagnosed with renovascular HTN at their institution [5].
Within the study period, 11 children had been diagnosed
with renovascular HTN. Of those 11, 5 children had abnor-
mal behavior prior to starting antihypertensive medications.
The reported abnormal behaviors included restlessness,
attention deﬁcit disorder (ADHD), oppositional deﬁant
disorder (ODD), temper tantrums, and sleep disturbances
(Table 1). Of the 5 children with abnormal behavior, 3 had
resolution of the behavior disturbances and the other 2
experienced great improvement after HTN treatment. This
study supplements other clinical observations that young
children may have behavioral disturbances secondary to
HTN [27]. These behaviors may go unrecognized due to the
diﬃculty of children to convey complaints in an eﬀective
manner. In a retrospective review, Croix and Feig reported
that of those patients aged 7–18 years old who were referred
to their institution for HTN and given that diagnosis,
the hypertensive children reported more complaints of
headache, daytime fatigue, diﬃculty with sleep initiation
and chest, or abdominal pain compared to normotensive
children[29]. The behavior changes may be attributed to4 International Journal of Pediatrics













nonorganic causes, and therefore HTN may go undiagnosed
until the other nonorganic causes are excluded.
In children with mild-to-moderate chronic kidney dis-
ease (CKD), elevated blood pressure was associated with
decreased performance on the Wechsler Abbreviated Scales
of Intelligence assessment (WASI) [30]. However, it is not
clear whether the eﬀect was due primarily to increased blood
pressure versus an interaction between blood pressure and
CKD.
The short-term eﬀects on pediatric patients can manifest
invariouspresentations—eithersubtlechangesinsymptoms
or visible eﬀects such as headache, seizures, or even change
in mental status. When there have been chronic elevations
in blood pressure, its eﬀects on pediatric patients are ill
deﬁned, especially the cognitive implications. Lande et al.
showed that patients with systolic blood pressures above
the 95th percentile for age, height, and sex had signiﬁcantly
lower cognitive test scores for memory, attention, and
concentration when compared to normotensive patients [3].
They went on to show that the use of antihypertensive
medication could reverse cognitive dysfunction, which has
also been demonstrated in the adult literature [20].
5. Discussion
Early diagnosis of HTN in pediatric patients may be
important to minimize and/or correct cognitive dysfunction.
With a multitude of eﬀective treatments and good responses
in children and adolescents with HTN, opportunities to
recover or preserve cognitive functions are readily available.
In adults, it has been shown that the use of antihypertensive
medication can have a positive impact on cognitive function
[20]. We hypothesize that antihypertensive treatment in
pediatrics can have beneﬁcial eﬀects on cognitive function,
but the guidelines for antihypertensive interventions and
extent of cognitive beneﬁts remain to be explored. Use
of a standardized deﬁnition of hypertension such as that
provided by the Fourth Report will better allow comparison
between future studies in this area.
In the adult study by Elias et al., they showed that
hypertensive adults performed poorer on a measure of
speed, memory, spatial localization, simple motor skills,
and learning [21]. Waldstein et al. also showed poorer
scores for learning and memory in hypertensive adults [22].
Miller et al. demonstrated that the restorative eﬀects of good
blood pressure control may not be limited to just the
cardiovascular system but have positive results in the brain
[20]. They showed improvement of behavioral-cognitive
scores with 15 months of antihypertensive treatment.
In pediatrics, the developing brain needs to be nurtured
to ensure good development. From an early age, parents
provide good nutrition, and stimuli and nurture their
childrentofosterbraindevelopment. Eﬀortstominimize the
harmful eﬀects of HTN on the developing brain should be
a priority in children and adolescents with HTN. Although
children with CKD may have other contributory factors,
it has been shown that children with hypertension have
decreased cognitive performance [30, 31]. Studies have
shown that hypertensive children and adolescents perform
poorer on cognitive tests when compared to normotensive
c o n t r o ls u b j e c t s[ 3]. They also develop behavior and mood
disturbances such as anxiety, depression, and problems with
attention and have somatic complaints such as headaches
and develop daytime fatigue along with diﬃculty with sleep
initiation [5, 29]. Since an improvement in cognitive testing
was seen in adults after antihypertensive treatment, it could
be speculated that similar results would be seen in pediatric
patients. If this is the case, then early and accurate diagnosis
of pediatric HTN can provide opportunities to limit any
possible cognitive dysfunction.
It has recently been shown that the combination of
both lifestyle modiﬁcation and medicines in children with
HTN can result in improvement in cardiovascular target
organ damage. Litwin et al. in 2010 showed reduction of left
ventricular mass index and carotid intima-media thickness
in 86 essential hypertensive children after 12 months of both
nonpharmacological and pharmacological therapy [32].
Nonpharmacological therapies included increasing amount
of physical activity and dietary changes. The beneﬁt of such
therapies on cognitive function and development in children
is not yet clear but, given the profound impact of cognitive
and cerebral function on adult outcomes and quality of life,
these issues deserve further exploration in children.
6. Conclusion
Pediatric HTN and its eﬀects on cognition and cogni-
tive development are emerging as important concerns in
children. There is an increasing body of literature that
indicates that (1) HTNadversely aﬀectscognitive function in
children and adolescents and (2) eﬀective treatment of HTN
can reverse some of these cognitive impairments. There is
evidencethatdeﬁcitsincognitionearlyinlifeadverselyaﬀect
future learning and social interaction [7]. Development of
an eﬃcient and eﬀective measurement tool for cognitive
functionwillbeinstrumentaltobetterdetectionofandinter-
vention for cognitive impairment in pediatric hypertensive
patients. More research is needed in this area because such
ﬁndings may be signiﬁcant and warrant further exploration
into the consequences of HTN in pediatric patients. Future
ﬁndings may have broad application to the areas of pediatric
cognition, development, quality of life, and brain health.International Journal of Pediatrics 5
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